D70.1
Billable codeAgranulocytosis secondary to cancer chemotherapy
The ICD-10 code for agranulocytosis secondary to cancer chemotherapy is D70.1.
Clinical notes
Code also
Two codes may be needed to fully describe a condition, but unlike Code First/Use Additional Code, the sequencing order is not mandated by convention.
- underlying neoplasm
Use additional code
This code represents an underlying condition. When a related manifestation is also present, coding convention calls for an additional code to be listed after this one.
- code for adverse effect, if applicable, to identify drug (T45.1X5)
Documentation support
General coding-documentation guidance — not a substitute for payer-specific requirements or professional coding judgment.
- •If the associated manifestation or related condition noted above is also documented, an additional code should be reported alongside this one.
- •As a general rule, code to the highest level of specificity supported by the documentation in the medical record.
Related codes in this category
- D70.0Congenital agranulocytosis
- D70.2Other drug-induced agranulocytosis
- D70.3Neutropenia due to infection
- D70.4Cyclic neutropenia
- D70.8Other neutropenia
- D70.9Neutropenia, unspecified
- D70.1Agranulocytosis secondary to cancer chemotherapy
ICD-9-CM equivalent
Informational only — GEM mappings are approximate, not guaranteed one-to-one equivalents. Verify before use in billing.
- 28803Approximate match
Associated MS-DRGs
D70.1 can serve as the principal diagnosis for these Medicare Severity Diagnosis-Related Groups.
Informational only — actual DRG assignment also depends on procedures, complications/comorbidities (CC/MCC), discharge status, and payer-specific rules not reflected here.
- DRG 808Major Hematological and Immunological Diagnoses Except Sickle Cell Crisis and Coagulation Disorders with MCC
- DRG 809Major Hematological and Immunological Diagnoses Except Sickle Cell Crisis and Coagulation Disorders with CC
- DRG 810Major Hematological and Immunological Diagnoses Except Sickle Cell Crisis and Coagulation Disorders without CC/MCC